Global Glucosamine and Chondroitin Sulfate Market Insights and Forecast to 2026

Publisher Name :
Date: 16-Jul-2020
No. of pages: 150
Inquire Before Buying

Glucosamine and Chondroitin Sulfate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucosamine and Chondroitin Sulfate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Glucosamine and Chondroitin Sulfate market is segmented into

- Food Grade

- Pharmaceutical Grade

Segment by Application, the Glucosamine and Chondroitin Sulfate market is segmented into

- Pharmaceutical

- Dietary Supplements

- Cosmetics

- Others

Regional and Country-level Analysis

The Glucosamine and Chondroitin Sulfate market is analysed and market size information is provided by regions (countries).

The key regions covered in the Glucosamine and Chondroitin Sulfate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Glucosamine and Chondroitin Sulfate Market Share Analysis

Glucosamine and Chondroitin Sulfate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucosamine and Chondroitin Sulfate business, the date to enter into the Glucosamine and Chondroitin Sulfate market, Glucosamine and Chondroitin Sulfate product introduction, recent developments, etc.

The major vendors covered:

- ANXIN

- WanTuMing Biological

- TSI Group

- Yantai Dongcheng

- Focus Chem

- YBCC

- Runxin Biotechnology

- ISBA

- Huiwen

- QJBCHINA

- Meitek (Synutra International)

- Hengjie Bio-Pharmaceuticals

- Nippon Zoki

- GGI

- Summit Nutritionals

- Sioux Pharm

- Ruikangda Biochemical

- Guanglong Biochem

- Pacific Rainbow

- Summit Nutritionals International

Global Glucosamine and Chondroitin Sulfate Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Glucosamine and Chondroitin Sulfate Product Introduction
1.2 Market Segments
1.3 Key Glucosamine and Chondroitin Sulfate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glucosamine and Chondroitin Sulfate Market Size Growth Rate by Type
1.4.2 Food Grade
1.4.3 Pharmaceutical Grade
1.5 Market by Application
1.5.1 Global Glucosamine and Chondroitin Sulfate Market Size Growth Rate by Application
1.5.2 Pharmaceutical
1.5.3 Dietary Supplements
1.5.4 Cosmetics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glucosamine and Chondroitin Sulfate Market Size, Estimates and Forecasts
2.1.1 Global Glucosamine and Chondroitin Sulfate Revenue 2015-2026
2.1.2 Global Glucosamine and Chondroitin Sulfate Sales 2015-2026
2.2 Global Glucosamine and Chondroitin Sulfate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glucosamine and Chondroitin Sulfate Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glucosamine and Chondroitin Sulfate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glucosamine and Chondroitin Sulfate Competitor Landscape by Players
3.1 Glucosamine and Chondroitin Sulfate Sales by Manufacturers
3.1.1 Glucosamine and Chondroitin Sulfate Sales by Manufacturers (2015-2020)
3.1.2 Glucosamine and Chondroitin Sulfate Sales Market Share by Manufacturers (2015-2020)
3.2 Glucosamine and Chondroitin Sulfate Revenue by Manufacturers
3.2.1 Glucosamine and Chondroitin Sulfate Revenue by Manufacturers (2015-2020)
3.2.2 Glucosamine and Chondroitin Sulfate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glucosamine and Chondroitin Sulfate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glucosamine and Chondroitin Sulfate Revenue in 2019
3.2.5 Global Glucosamine and Chondroitin Sulfate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glucosamine and Chondroitin Sulfate Price by Manufacturers
3.4 Glucosamine and Chondroitin Sulfate Manufacturing Base Distribution, Product Types
3.4.1 Glucosamine and Chondroitin Sulfate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucosamine and Chondroitin Sulfate Product Type
3.4.3 Date of International Manufacturers Enter into Glucosamine and Chondroitin Sulfate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glucosamine and Chondroitin Sulfate Market Size by Type (2015-2020)
4.1.1 Global Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020)
4.1.2 Global Glucosamine and Chondroitin Sulfate Revenue by Type (2015-2020)
4.1.3 Glucosamine and Chondroitin Sulfate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glucosamine and Chondroitin Sulfate Market Size Forecast by Type (2021-2026)
4.2.1 Global Glucosamine and Chondroitin Sulfate Sales Forecast by Type (2021-2026)
4.2.2 Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Type (2021-2026)
4.2.3 Glucosamine and Chondroitin Sulfate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glucosamine and Chondroitin Sulfate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glucosamine and Chondroitin Sulfate Market Size by Application (2015-2020)
5.1.1 Global Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020)
5.1.2 Global Glucosamine and Chondroitin Sulfate Revenue by Application (2015-2020)
5.1.3 Glucosamine and Chondroitin Sulfate Price by Application (2015-2020)
5.2 Glucosamine and Chondroitin Sulfate Market Size Forecast by Application (2021-2026)
5.2.1 Global Glucosamine and Chondroitin Sulfate Sales Forecast by Application (2021-2026)
5.2.2 Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucosamine and Chondroitin Sulfate Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glucosamine and Chondroitin Sulfate by Country
6.1.1 North America Glucosamine and Chondroitin Sulfate Sales by Country
6.1.2 North America Glucosamine and Chondroitin Sulfate Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Type
6.3 North America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Application
7 Europe
7.1 Europe Glucosamine and Chondroitin Sulfate by Country
7.1.1 Europe Glucosamine and Chondroitin Sulfate Sales by Country
7.1.2 Europe Glucosamine and Chondroitin Sulfate Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucosamine and Chondroitin Sulfate Market Facts & Figures by Type
7.3 Europe Glucosamine and Chondroitin Sulfate Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glucosamine and Chondroitin Sulfate by Region
8.1.1 Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Region
8.1.2 Asia Pacific Glucosamine and Chondroitin Sulfate Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glucosamine and Chondroitin Sulfate Market Facts & Figures by Type
8.3 Asia Pacific Glucosamine and Chondroitin Sulfate Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glucosamine and Chondroitin Sulfate by Country
9.1.1 Latin America Glucosamine and Chondroitin Sulfate Sales by Country
9.1.2 Latin America Glucosamine and Chondroitin Sulfate Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Type
9.3 Central & South America Glucosamine and Chondroitin Sulfate Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glucosamine and Chondroitin Sulfate by Country
10.1.1 Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country
10.1.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Facts & Figures by Type
10.3 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Facts & Figures by Application
11 Company Profiles
11.1 ANXIN
11.1.1 ANXIN Corporation Information
11.1.2 ANXIN Description and Business Overview
11.1.3 ANXIN Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ANXIN Glucosamine and Chondroitin Sulfate Products Offered
11.1.5 ANXIN Related Developments
11.2 WanTuMing Biological
11.2.1 WanTuMing Biological Corporation Information
11.2.2 WanTuMing Biological Description and Business Overview
11.2.3 WanTuMing Biological Sales, Revenue and Gross Margin (2015-2020)
11.2.4 WanTuMing Biological Glucosamine and Chondroitin Sulfate Products Offered
11.2.5 WanTuMing Biological Related Developments
11.3 TSI Group
11.3.1 TSI Group Corporation Information
11.3.2 TSI Group Description and Business Overview
11.3.3 TSI Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 TSI Group Glucosamine and Chondroitin Sulfate Products Offered
11.3.5 TSI Group Related Developments
11.4 Yantai Dongcheng
11.4.1 Yantai Dongcheng Corporation Information
11.4.2 Yantai Dongcheng Description and Business Overview
11.4.3 Yantai Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Yantai Dongcheng Glucosamine and Chondroitin Sulfate Products Offered
11.4.5 Yantai Dongcheng Related Developments
11.5 Focus Chem
11.5.1 Focus Chem Corporation Information
11.5.2 Focus Chem Description and Business Overview
11.5.3 Focus Chem Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Focus Chem Glucosamine and Chondroitin Sulfate Products Offered
11.5.5 Focus Chem Related Developments
11.6 YBCC
11.6.1 YBCC Corporation Information
11.6.2 YBCC Description and Business Overview
11.6.3 YBCC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 YBCC Glucosamine and Chondroitin Sulfate Products Offered
11.6.5 YBCC Related Developments
11.7 Runxin Biotechnology
11.7.1 Runxin Biotechnology Corporation Information
11.7.2 Runxin Biotechnology Description and Business Overview
11.7.3 Runxin Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Runxin Biotechnology Glucosamine and Chondroitin Sulfate Products Offered
11.7.5 Runxin Biotechnology Related Developments
11.8 ISBA
11.8.1 ISBA Corporation Information
11.8.2 ISBA Description and Business Overview
11.8.3 ISBA Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ISBA Glucosamine and Chondroitin Sulfate Products Offered
11.8.5 ISBA Related Developments
11.9 Huiwen
11.9.1 Huiwen Corporation Information
11.9.2 Huiwen Description and Business Overview
11.9.3 Huiwen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Huiwen Glucosamine and Chondroitin Sulfate Products Offered
11.9.5 Huiwen Related Developments
11.10 QJBCHINA
11.10.1 QJBCHINA Corporation Information
11.10.2 QJBCHINA Description and Business Overview
11.10.3 QJBCHINA Sales, Revenue and Gross Margin (2015-2020)
11.10.4 QJBCHINA Glucosamine and Chondroitin Sulfate Products Offered
11.10.5 QJBCHINA Related Developments
11.1 ANXIN
11.1.1 ANXIN Corporation Information
11.1.2 ANXIN Description and Business Overview
11.1.3 ANXIN Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ANXIN Glucosamine and Chondroitin Sulfate Products Offered
11.1.5 ANXIN Related Developments
11.12 Hengjie Bio-Pharmaceuticals
11.12.1 Hengjie Bio-Pharmaceuticals Corporation Information
11.12.2 Hengjie Bio-Pharmaceuticals Description and Business Overview
11.12.3 Hengjie Bio-Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Hengjie Bio-Pharmaceuticals Products Offered
11.12.5 Hengjie Bio-Pharmaceuticals Related Developments
11.13 Nippon Zoki
11.13.1 Nippon Zoki Corporation Information
11.13.2 Nippon Zoki Description and Business Overview
11.13.3 Nippon Zoki Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Nippon Zoki Products Offered
11.13.5 Nippon Zoki Related Developments
11.14 GGI
11.14.1 GGI Corporation Information
11.14.2 GGI Description and Business Overview
11.14.3 GGI Sales, Revenue and Gross Margin (2015-2020)
11.14.4 GGI Products Offered
11.14.5 GGI Related Developments
11.15 Summit Nutritionals
11.15.1 Summit Nutritionals Corporation Information
11.15.2 Summit Nutritionals Description and Business Overview
11.15.3 Summit Nutritionals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Summit Nutritionals Products Offered
11.15.5 Summit Nutritionals Related Developments
11.16 Sioux Pharm
11.16.1 Sioux Pharm Corporation Information
11.16.2 Sioux Pharm Description and Business Overview
11.16.3 Sioux Pharm Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sioux Pharm Products Offered
11.16.5 Sioux Pharm Related Developments
11.17 Ruikangda Biochemical
11.17.1 Ruikangda Biochemical Corporation Information
11.17.2 Ruikangda Biochemical Description and Business Overview
11.17.3 Ruikangda Biochemical Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Ruikangda Biochemical Products Offered
11.17.5 Ruikangda Biochemical Related Developments
11.18 Guanglong Biochem
11.18.1 Guanglong Biochem Corporation Information
11.18.2 Guanglong Biochem Description and Business Overview
11.18.3 Guanglong Biochem Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Guanglong Biochem Products Offered
11.18.5 Guanglong Biochem Related Developments
11.19 Pacific Rainbow
11.19.1 Pacific Rainbow Corporation Information
11.19.2 Pacific Rainbow Description and Business Overview
11.19.3 Pacific Rainbow Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Pacific Rainbow Products Offered
11.19.5 Pacific Rainbow Related Developments
11.20 Summit Nutritionals International
11.20.1 Summit Nutritionals International Corporation Information
11.20.2 Summit Nutritionals International Description and Business Overview
11.20.3 Summit Nutritionals International Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Summit Nutritionals International Products Offered
11.20.5 Summit Nutritionals International Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glucosamine and Chondroitin Sulfate Market Estimates and Projections by Region
12.1.1 Global Glucosamine and Chondroitin Sulfate Sales Forecast by Regions 2021-2026
12.1.2 Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Regions 2021-2026
12.2 North America Glucosamine and Chondroitin Sulfate Market Size Forecast (2021-2026)
12.2.1 North America: Glucosamine and Chondroitin Sulfate Sales Forecast (2021-2026)
12.2.2 North America: Glucosamine and Chondroitin Sulfate Revenue Forecast (2021-2026)
12.2.3 North America: Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2021-2026)
12.3 Europe Glucosamine and Chondroitin Sulfate Market Size Forecast (2021-2026)
12.3.1 Europe: Glucosamine and Chondroitin Sulfate Sales Forecast (2021-2026)
12.3.2 Europe: Glucosamine and Chondroitin Sulfate Revenue Forecast (2021-2026)
12.3.3 Europe: Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glucosamine and Chondroitin Sulfate Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glucosamine and Chondroitin Sulfate Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glucosamine and Chondroitin Sulfate Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glucosamine and Chondroitin Sulfate Market Size Forecast by Region (2021-2026)
12.5 Latin America Glucosamine and Chondroitin Sulfate Market Size Forecast (2021-2026)
12.5.1 Latin America: Glucosamine and Chondroitin Sulfate Sales Forecast (2021-2026)
12.5.2 Latin America: Glucosamine and Chondroitin Sulfate Revenue Forecast (2021-2026)
12.5.3 Latin America: Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glucosamine and Chondroitin Sulfate Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glucosamine and Chondroitin Sulfate Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glucosamine and Chondroitin Sulfate Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glucosamine and Chondroitin Sulfate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Glucosamine and Chondroitin Sulfate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucosamine and Chondroitin Sulfate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Glucosamine and Chondroitin Sulfate Market Segments
Table 2. Ranking of Global Top Glucosamine and Chondroitin Sulfate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glucosamine and Chondroitin Sulfate Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Food Grade
Table 5. Major Manufacturers of Pharmaceutical Grade
Table 6. Global Glucosamine and Chondroitin Sulfate Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Glucosamine and Chondroitin Sulfate Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Glucosamine and Chondroitin Sulfate Sales by Regions 2015-2020 (K Units)
Table 9. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Regions (2015-2020)
Table 10. Global Glucosamine and Chondroitin Sulfate Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Glucosamine and Chondroitin Sulfate Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Glucosamine and Chondroitin Sulfate Sales Share by Manufacturers (2015-2020)
Table 13. Global Glucosamine and Chondroitin Sulfate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Glucosamine and Chondroitin Sulfate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucosamine and Chondroitin Sulfate as of 2019)
Table 15. Glucosamine and Chondroitin Sulfate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Glucosamine and Chondroitin Sulfate Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Glucosamine and Chondroitin Sulfate Price (2015-2020) (USD/Unit)
Table 18. Glucosamine and Chondroitin Sulfate Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Glucosamine and Chondroitin Sulfate Product Type
Table 20. Date of International Manufacturers Enter into Glucosamine and Chondroitin Sulfate Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 23. Global Glucosamine and Chondroitin Sulfate Sales Share by Type (2015-2020)
Table 24. Global Glucosamine and Chondroitin Sulfate Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Glucosamine and Chondroitin Sulfate Revenue Share by Type (2015-2020)
Table 26. Glucosamine and Chondroitin Sulfate Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 28. Global Glucosamine and Chondroitin Sulfate Sales Share by Application (2015-2020)
Table 29. North America Glucosamine and Chondroitin Sulfate Sales by Country (2015-2020) (K Units)
Table 30. North America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2015-2020)
Table 31. North America Glucosamine and Chondroitin Sulfate Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2015-2020)
Table 33. North America Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 34. North America Glucosamine and Chondroitin Sulfate Sales Market Share by Type (2015-2020)
Table 35. North America Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 36. North America Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2015-2020)
Table 37. Europe Glucosamine and Chondroitin Sulfate Sales by Country (2015-2020) (K Units)
Table 38. Europe Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2015-2020)
Table 39. Europe Glucosamine and Chondroitin Sulfate Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2015-2020)
Table 41. Europe Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 42. Europe Glucosamine and Chondroitin Sulfate Sales Market Share by Type (2015-2020)
Table 43. Europe Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 44. Europe Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Glucosamine and Chondroitin Sulfate Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Glucosamine and Chondroitin Sulfate Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Glucosamine and Chondroitin Sulfate Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2015-2020)
Table 53. Latin America Glucosamine and Chondroitin Sulfate Sales by Country (2015-2020) (K Units)
Table 54. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Glucosamine and Chondroitin Sulfate Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2015-2020)
Table 57. Latin America Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 58. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share by Type (2015-2020)
Table 59. Latin America Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 60. Latin America Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Glucosamine and Chondroitin Sulfate Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Glucosamine and Chondroitin Sulfate Sales Market Share by Application (2015-2020)
Table 69. ANXIN Corporation Information
Table 70. ANXIN Description and Major Businesses
Table 71. ANXIN Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. ANXIN Product
Table 73. ANXIN Recent Development
Table 74. WanTuMing Biological Corporation Information
Table 75. WanTuMing Biological Description and Major Businesses
Table 76. WanTuMing Biological Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. WanTuMing Biological Product
Table 78. WanTuMing Biological Recent Development
Table 79. TSI Group Corporation Information
Table 80. TSI Group Description and Major Businesses
Table 81. TSI Group Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. TSI Group Product
Table 83. TSI Group Recent Development
Table 84. Yantai Dongcheng Corporation Information
Table 85. Yantai Dongcheng Description and Major Businesses
Table 86. Yantai Dongcheng Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Yantai Dongcheng Product
Table 88. Yantai Dongcheng Recent Development
Table 89. Focus Chem Corporation Information
Table 90. Focus Chem Description and Major Businesses
Table 91. Focus Chem Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Focus Chem Product
Table 93. Focus Chem Recent Development
Table 94. YBCC Corporation Information
Table 95. YBCC Description and Major Businesses
Table 96. YBCC Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. YBCC Product
Table 98. YBCC Recent Development
Table 99. Runxin Biotechnology Corporation Information
Table 100. Runxin Biotechnology Description and Major Businesses
Table 101. Runxin Biotechnology Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Runxin Biotechnology Product
Table 103. Runxin Biotechnology Recent Development
Table 104. ISBA Corporation Information
Table 105. ISBA Description and Major Businesses
Table 106. ISBA Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. ISBA Product
Table 108. ISBA Recent Development
Table 109. Huiwen Corporation Information
Table 110. Huiwen Description and Major Businesses
Table 111. Huiwen Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Huiwen Product
Table 113. Huiwen Recent Development
Table 114. QJBCHINA Corporation Information
Table 115. QJBCHINA Description and Major Businesses
Table 116. QJBCHINA Glucosamine and Chondroitin Sulfate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. QJBCHINA Product
Table 118. QJBCHINA Recent Development
Table 119. Meitek (Synutra International) Corporation Information
Table 120. Meitek (Synutra International) Description and Major Businesses
Table 121. Meitek (Synutra International) Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Meitek (Synutra International) Product
Table 123. Meitek (Synutra International) Recent Development
Table 124. Hengjie Bio-Pharmaceuticals Corporation Information
Table 125. Hengjie Bio-Pharmaceuticals Description and Major Businesses
Table 126. Hengjie Bio-Pharmaceuticals Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Hengjie Bio-Pharmaceuticals Product
Table 128. Hengjie Bio-Pharmaceuticals Recent Development
Table 129. Nippon Zoki Corporation Information
Table 130. Nippon Zoki Description and Major Businesses
Table 131. Nippon Zoki Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Nippon Zoki Product
Table 133. Nippon Zoki Recent Development
Table 134. GGI Corporation Information
Table 135. GGI Description and Major Businesses
Table 136. GGI Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. GGI Product
Table 138. GGI Recent Development
Table 139. Summit Nutritionals Corporation Information
Table 140. Summit Nutritionals Description and Major Businesses
Table 141. Summit Nutritionals Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Summit Nutritionals Product
Table 143. Summit Nutritionals Recent Development
Table 144. Sioux Pharm Corporation Information
Table 145. Sioux Pharm Description and Major Businesses
Table 146. Sioux Pharm Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Sioux Pharm Product
Table 148. Sioux Pharm Recent Development
Table 149. Ruikangda Biochemical Corporation Information
Table 150. Ruikangda Biochemical Description and Major Businesses
Table 151. Ruikangda Biochemical Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Ruikangda Biochemical Product
Table 153. Ruikangda Biochemical Recent Development
Table 154. Guanglong Biochem Corporation Information
Table 155. Guanglong Biochem Description and Major Businesses
Table 156. Guanglong Biochem Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Guanglong Biochem Product
Table 158. Guanglong Biochem Recent Development
Table 159. Pacific Rainbow Corporation Information
Table 160. Pacific Rainbow Description and Major Businesses
Table 161. Pacific Rainbow Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Pacific Rainbow Product
Table 163. Pacific Rainbow Recent Development
Table 164. Summit Nutritionals International Corporation Information
Table 165. Summit Nutritionals International Description and Major Businesses
Table 166. Summit Nutritionals International Glucosamine and Chondroitin Sulfate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Summit Nutritionals International Product
Table 168. Summit Nutritionals International Recent Development
Table 169. Global Glucosamine and Chondroitin Sulfate Sales Forecast by Regions (2021-2026) (K Units)
Table 170. Global Glucosamine and Chondroitin Sulfate Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Glucosamine and Chondroitin Sulfate Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Glucosamine and Chondroitin Sulfate Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2021-2026) (K Units)
Table 174. North America: Glucosamine and Chondroitin Sulfate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2021-2026) (K Units)
Table 176. Europe: Glucosamine and Chondroitin Sulfate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Glucosamine and Chondroitin Sulfate Sales Forecast by Region (2021-2026) (K Units)
Table 178. Asia Pacific: Glucosamine and Chondroitin Sulfate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2021-2026) (K Units)
Table 180. Latin America: Glucosamine and Chondroitin Sulfate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Glucosamine and Chondroitin Sulfate Sales Forecast by Country (2021-2026) (K Units)
Table 182. Middle East and Africa: Glucosamine and Chondroitin Sulfate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Glucosamine and Chondroitin Sulfate Players
Table 187. Glucosamine and Chondroitin Sulfate Customers List
Table 188. Glucosamine and Chondroitin Sulfate Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucosamine and Chondroitin Sulfate Product Picture
Figure 2. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Type in 2020 & 2026
Figure 3. Food Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceutical
Figure 7. Dietary Supplements
Figure 8. Cosmetics
Figure 9. Others
Figure 10. Glucosamine and Chondroitin Sulfate Report Years Considered
Figure 11. Global Glucosamine and Chondroitin Sulfate Market Size 2015-2026 (US$ Million)
Figure 12. Global Glucosamine and Chondroitin Sulfate Sales 2015-2026 (K Units)
Figure 13. Global Glucosamine and Chondroitin Sulfate Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Glucosamine and Chondroitin Sulfate Sales Market Share by Region (2015-2020)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs